Lux Capital has backed many of the familiar startup faces in Emerging Tech Brew. Today, the VC firm is launching a new season of Futura, its web series exploring the operations of portfolio companies. Futura S2 includes startups like Anduril, Cala Health, and Saildrone.
Emerging Tech Brew recently caught up with Lux cofounder Josh Wolfe to discuss these investments and more. Note: This interview has been edited for clarity and length.
Thinking about the new season of Futura, why is storytelling an effective way to highlight the projects your portfolio companies are working on?
I think you know this from what you do on a daily basis, but we are storytelling creatures and social primates. Futura tells the stories of the individuals, mavericks, and scientists we like to celebrate and invest in, who believe something that everyone else doesnt believe. Or the guy or girl with a chip on their shoulder and something to prove.
In general, having trusted insider access to people who are quite literally inventing the future is special. Being able to asymmetrically bring that to the masses is the motive for why we do it.
Whats it like researching, investing, and doing diligence in companies that, as you say are, inventing the future?
On the one hand, Im always quite envious of people who have those early revenue metrics and can say heres where well be in a quarter or year later. Oftentimes when we're investing, we like to say that we believe before others might understand, so that has us investing in the cutting-edge.
Were constantly assessing the people first and foremost. Are they for real or full of shit? Thats the number one thing we have to assess early on. Its really hard to know at the moment of inception whether someone is delusional or visionary, if theyre a huckster or someone thats going to go change the world.
Take the person coming out of their garage saying they have some new flux capacitor. Were going to treat that very skeptically, versus a PhD whos highly esteemed by their peers, has lots of polished academic research, and a commercial instinct. Thats way more credible.
How about evaluating or validating the technology itself?
The Lux team is very diverse and very technical, with backgrounds in neuroscience, electrical engineering, mechanical engineering, stem cell biology, and material science. But every technology reveals our own ignorance, so then the most important question is: Does it work?
Its amazing how many investors will invest in something and then become pot-committed. Its the worst kind of psychological biascommitment bias. We ask: How much money accomplishes what, in what period of time, and who will care? Theres usually an Oh wow, holy shit moment where we get very excited to double down. Thats when we go from putting millions of dollars to tens of millions of dollars or more into a company.
When you have that feeling that invokes the Arthur C. Clarke quote [Any sufficiently advanced technology is indistinguishable from magic], thats the greatest risk-reducer of all.
What else is a key differentiator for Lux?
One part humility, one part paranoia. Theres a phenomenon I call 100-0-100. Its a cute way of saying with 100% certainty well be investing in the most cutting-edge stuff people can imagine over the next two years. Zero certainty what those things will actually be. Thats the intellectual honesty. The last 100% is the confidence of where we will find the next investments, which is at the edge of our already cutting-edge companies. One leads to the next one, which leads to the next one.
I hadn't really thought about the tech crossover between startups working on very different problems.
When we invest in one company, it can lead to knowledge that lets us find others. A priori, you never know what the second or third company will be. But just by having a sufficient amount of paranoia and curiositythe confidence of staying at the cutting-edge on this treadmill thats always picking up a bit fasterthat can lead you to the next company.
VC is the only asset class where you can get legal inside information about whats happening. You start to see white space and whos entering it.
Take Cala from Season 2. In CTRL-labs case from Season 1, youre reading from the brain using pretty sophisticated software, sensors, and machine learning. Youre reading what the brain intends to do; its more about intention capture. Cala is the opposite. How do we take the same wrist worn device and instead of reading from the brain write to the brain? How do we take people with essential tremors and through a device give them the stability of motions we all take for granted? Theyre helping restore dignity to someone that suffers, through technology.
Lets unpack a term you use frequentlydirectional arrows of progress. Can you explain that a bit?
Technologies are directionally predictable. The hardest thing to predict is the social piece of a technology. Its not what happens when one person has a phone, its when everyone does. Right now, you can see that with e-commerce, videoconferencing, and online learning.
As for technological arrows of progress, Im a big student of history. I like looking at how technology evolves. There's a directional arrow of progress that reduces entropy. Theres more information content in the next device. Theres less waste. It tends to be more efficient, a higher density per unit of raw material.
Transportation is an example. We went from horses to horse drawn carriages to cars to electric cars to an autonomous car. Were not going back to horses.
Now lets pivot to our current situation. How exposed are your portfolio companies to the coronavirus?
Ill start with the macro and then give you a post-pandemic prescription. Macro, everybody is suffering in some way. Its more than an economic or medical crisis; its a human crisis.
On a more technical and practical matter, weve always been more on the bearish side of things. Its this weird dichotomy where were ebullient optimists about the future but were generally very skeptical about human nature and markets, which are a collective of human nature. Were always admonishing our companies with this line: Failure comes from a failure of imagination.
So theyve been admonished to have rainy day money, expect the worst, and plan for bad scenarios. Now, we never prophesied a pandemic [editors note: us as well], but Ive been amazed at how quickly and swiftly theyve acted. Of the 130 companies we have, Ive seen five where they had financing that was going to close, or was at risk of closing, where the business wasnt going that well. They were likely to succumb.
Weve also seen some companies that have dropped everything to help. Shapeways has been shipping over 10,000 PPE to 10 different NYC hospitals. Desktop Metal is helping produce swabs for testing. It showed in a crisis how you can go from centralized manufacturing to distributed and do it in a very agile fashion.
I know you started as an expert in nanotech. What should our younger readers (potential future entrepreneurs and investors) be focused on? Should students or early-stage career folks focus on going really, really deep on something technical or scientific theyre passionate about?
I think the best thing that can serve you is science and technology. Id read everything Kevin Kelly ever wrote. A good understanding of human nature and psychology also helps. When our companies do or dont succeed, its because of the people. Its never because the technology didnt work.
Anywhere there are structural barriers and therefore competitive advantage is really important to identify. Id emphasize understanding the great competitors and clever things they did to make it harder to compete with them. Some of the greatest entrepreneurs have always been very thoughtful about that. And you yourself have to have a competitive advantage.
Any area we go into, its good to become obsessive. That way, when youre talking to someone with a PhD whos super technical, theyll take you seriously. I knew nothing about brain machine interfaces or nuclear but then became obsessed.
What science fiction are you currently obsessed with?
Currently, I think Chinese science fiction is sweeping and sophisticated. Its rooted in physics, computer science, and astronomy. Its not fantasy. Also the new William Gibson book, Agency. That was outstanding because its a real near-term prognostication of how technology is likely to evolve. A version of Black Mirror.
The gap between sci-fi and when it becomes real is just getting shorter and shorter.
Originally posted here:
A Q&A With Josh Wolfe of Lux Capital - Morning Brew
- Distinguished investigator brings expertise in genetics and cell biology to Texas A&M AgriLife - AgriLife Today - October 26th, 2024 [October 26th, 2024]
- Institute of Molecular and Cell Biology (IMCB) - Agency for Science, Technology and Research (A*STAR) - October 13th, 2024 [October 13th, 2024]
- Joseph Gall, father of modern cell biology, dead at 96 - Carnegie Institution for Science - September 15th, 2024 [September 15th, 2024]
- A dual role of ERGIC-localized Rabs in TMED10-mediated unconventional protein secretion - Nature.com - June 27th, 2024 [June 27th, 2024]
- Yoshihiro Yoneda Appointed President of the International Human Frontier Science Program Organization - PR Newswire - June 27th, 2024 [June 27th, 2024]
- A new way to measure ageing and disease risk with the protein aggregation clock - EurekAlert - June 18th, 2024 [June 18th, 2024]
- How Flow Cytometry Spurred Cell Biology - The Scientist - June 18th, 2024 [June 18th, 2024]
- Building Cells from the Bottom Up - The Scientist - June 18th, 2024 [June 18th, 2024]
- From Code to Creature - The Scientist - June 18th, 2024 [June 18th, 2024]
- Adding intrinsically disordered proteins to biological ageing clocks - Nature.com - May 24th, 2024 [May 24th, 2024]
- Advancing Cell Biology and Cancer Research via Cell Culture and Microscopy Imaging Techniques - Lab Manager Magazine - May 24th, 2024 [May 24th, 2024]
- Study explores how different modes of cell division evolved in close relatives of fungi and animals - News-Medical.Net - May 24th, 2024 [May 24th, 2024]
- Solving the Wnt nuclear puzzle - Nature.com - May 24th, 2024 [May 24th, 2024]
- Prof. Jay Shendure Joins Somite Therapeutics as Scientific Co-founder - BioSpace - May 24th, 2024 [May 24th, 2024]
- One essential step for a germ cell, one giant leap for the future of reproductive medicine - EurekAlert - May 24th, 2024 [May 24th, 2024]
- May: academy-medical-sciences | News and features - University of Bristol - May 24th, 2024 [May 24th, 2024]
- Universal tool for tracking cell-to-cell interactions - ASBMB Today - May 24th, 2024 [May 24th, 2024]
- Close Encounters of Skin and Nerve Cells - The Scientist - April 15th, 2024 [April 15th, 2024]
- OrthoID: Decoding Cellular Conversations with Cutting-Edge Technology - yTech - April 15th, 2024 [April 15th, 2024]
- Impact of aldehydes on DNA damage and aging - EurekAlert - April 15th, 2024 [April 15th, 2024]
- Redefining Cell Biology: Nondestructive Genetic Insights With Raman Spectroscopy - SciTechDaily - March 29th, 2024 [March 29th, 2024]
- Scientists Unravel the Unusual Cell Biology Behind Toxic Algal Blooms - SciTechDaily - March 19th, 2024 [March 19th, 2024]
- Ancient retroviruses played a key role in the evolution of vertebrate brains - EurekAlert - February 21st, 2024 [February 21st, 2024]
- Singapore scientists uncover a crucial link between cholesterol synthesis and cancer progression - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Scientists uncover a way to "hack" neurons' internal clocks to speed up brain cell development - News-Medical.Net - February 4th, 2024 [February 4th, 2024]
- First atomic-scale 'movie' of microtubules under construction, a key process for cell division - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Small RNAs take on the big task of helping skin wounds heal better and faster with minimal scarring - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Shengjie Feng channels the powers of cryogenic electron microscopy - Newswise - January 19th, 2024 [January 19th, 2024]
- Study pinpoints breast cancer cells-of-origi - EurekAlert - January 19th, 2024 [January 19th, 2024]
- New analysis of cancer cells identifies 370 targets for smarter, personalized treatments - News-Medical.Net - January 19th, 2024 [January 19th, 2024]
- EU funding for pioneering research on the treatment of gliomas - EurekAlert - January 19th, 2024 [January 19th, 2024]
- The future of mRNA biology and AI convergence - Drug Target Review - December 22nd, 2023 [December 22nd, 2023]
- The future of artificial breast milk, according to one lab - Quartz - December 22nd, 2023 [December 22nd, 2023]
- Shedding new light on the hidden organization of the cytoplasm - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
- Bugs that help bugs: How environmental microbes boost fruit fly reproduction - EurekAlert - December 22nd, 2023 [December 22nd, 2023]
- Cells Move in Groups Differently Than They Do When Alone - NYU Langone Health - December 14th, 2023 [December 14th, 2023]
- Cells move in groups differently than they do when alone - EurekAlert - December 14th, 2023 [December 14th, 2023]
- Seattle Hub for Synthetic Biology plans to transform cells into tiny recording devices - GeekWire - December 14th, 2023 [December 14th, 2023]
- Virginia Tech and Weizmann Institute of Science tackle cell ... - Virginia Tech - October 16th, 2023 [October 16th, 2023]
- Vast diversity of human brain cell types revealed in trove of new ... - Spectrum - Autism Research News - October 16th, 2023 [October 16th, 2023]
- Singamaneni to develop advanced protein imaging method - The ... - Washington University in St. Louis - October 16th, 2023 [October 16th, 2023]
- Researchers find certain cancers can activate 'enhancer' in the ... - University of Toronto - October 16th, 2023 [October 16th, 2023]
- 2023 Hettleman Prizes awarded to five exceptional early-career ... - UNC Research - October 16th, 2023 [October 16th, 2023]
- Faeth Therapeutics Announces National Academy of Medicine ... - BioSpace - October 16th, 2023 [October 16th, 2023]
- From Migrant Farm Worker to Duke Scientist, Everardo Macias ... - Duke University School of Medicine - October 16th, 2023 [October 16th, 2023]
- Finding the golden ticket? Cyclin T1 is required for HIV-1 latency ... - Fred Hutch News Service - October 16th, 2023 [October 16th, 2023]
- Spermidine May Improve Egg Health and Fertility - Lifespan.io News - October 16th, 2023 [October 16th, 2023]
- Molecule discovered that grows bigger and stronger muscles - Earth.com - October 16th, 2023 [October 16th, 2023]
- SGIOY: 3 Biotech Stocks With Potential Future Gains - StockNews.com - October 16th, 2023 [October 16th, 2023]
- Association for Molecular Pathology Publishes Best Practice ... - Technology Networks - October 16th, 2023 [October 16th, 2023]
- A new cell type with links to gastric cancer steps up for its mugshot - Fred Hutch News Service - October 16th, 2023 [October 16th, 2023]
- Programmed cell death may be 1.8 billion year - EurekAlert - October 16th, 2023 [October 16th, 2023]
- New study confirms presence of flesh-eating and illness-causing ... - Science Daily - October 16th, 2023 [October 16th, 2023]
- New Institute for Immunologic Intervention (3i) at the Hackensack ... - Hackensack Meridian Health - October 16th, 2023 [October 16th, 2023]
- Post-doctoral Fellow in Cancer Biology in the Department of ... - Times Higher Education - October 16th, 2023 [October 16th, 2023]
- Scientists uncover key enzymes involved in bacterial pathogenicity - News-Medical.Net - October 16th, 2023 [October 16th, 2023]
- B cell response after influenza vaccine in young and older adults - EurekAlert - October 16th, 2023 [October 16th, 2023]
- Post-doctoral researcher in yeast cell biology job with UNIVERSITY ... - Times Higher Education - April 8th, 2023 [April 8th, 2023]
- expert reaction to study looking at creating embryo-like structures ... - Science Media Centre - April 8th, 2023 [April 8th, 2023]
- UCF Bone Researcher Receives National Recognition - UCF - April 8th, 2023 [April 8th, 2023]
- PhenomeX to Participate in American Association of Cancer ... - BioSpace - April 8th, 2023 [April 8th, 2023]
- Inland Empire stem-cell therapy gets $2.9 million booster - UC Riverside - April 8th, 2023 [April 8th, 2023]
- New finding in roundworms upends classical thinking about animal cell differentiation - News-Medical.Net - April 8th, 2023 [April 8th, 2023]
- Biology's unsolved chicken-or-egg problem: Where did life come from? - Big Think - April 8th, 2023 [April 8th, 2023]
- Azacitidine in Combination With Trametinib May Be Effective for ... - The ASCO Post - April 8th, 2023 [April 8th, 2023]
- Researchers clear the way for well-rounded view of cellular defects - Phys.org - April 8th, 2023 [April 8th, 2023]
- We were dancing around the lab cellular identity discovery has potential to impact cancer treatments - Newswise - April 8th, 2023 [April 8th, 2023]
- Environmental stressors' effect on gene expression explored in lecture - Environmental Factor Newsletter - April 8th, 2023 [April 8th, 2023]
- RNA therapy restores gene function in monkeys modeling ... - Spectrum - Autism Research News - April 8th, 2023 [April 8th, 2023]
- Traumatic brain injury interferes with immune system cells' recycling ... - Science Daily - April 8th, 2023 [April 8th, 2023]
- Lab-grown fat could give cultured meat real flavor and texture - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Researchers reveal mechanism of polarized cortex assembly in migrating cells - Phys.org - April 8th, 2023 [April 8th, 2023]
- Probing Selfish Centromeres Unveils an Evolutionary Arms Race - The Scientist - April 8th, 2023 [April 8th, 2023]
- Meet the 2023 Outstanding Graduating Students - UMaine News ... - University of Maine - April 8th, 2023 [April 8th, 2023]
- The Worlds Sexiest Fragrance Unveiled, But Its Not For You - Revyuh - April 8th, 2023 [April 8th, 2023]
- City of Hope appoints John D. Carpten, Ph.D., as director of its ... - BioSpace - April 8th, 2023 [April 8th, 2023]
- Modernized Algorithm Predicts Drug Targets for SARS-CoV-2, Other ... - GenomeWeb - April 8th, 2023 [April 8th, 2023]
- BU researcher wins $3.9 million NIH grant to develop novel therapeutic modalities for Alzheimer's - News-Medical.Net - April 8th, 2023 [April 8th, 2023]
- Providing critical insights for animal development - HKU biologists ... - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Students Express Frustrations About the Middle Class Scholarship - The Triton - April 8th, 2023 [April 8th, 2023]